Source: Journal of Personalized Medicine. Unidade: FOB
Subjects: OBESIDADE, AGENTES DOPAMINÉRGICOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Bárbara Ferraz et al. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, for obese patients: a systematic review and meta-analysis. Journal of Personalized Medicine, v. 13, 2023Tradução . . Disponível em: https://doi.org/10.3390/jpm13101460. Acesso em: 07 nov. 2024.APA
Barbosa, B. F., Moraes, F. C. A. de, Barbosa, C. B., Santos, P. T. K. P., Silva, I. P. da, Silva, B. A. A. da, et al. (2023). Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, for obese patients: a systematic review and meta-analysis. Journal of Personalized Medicine, 13. doi:10.3390/jpm13101460NLM
Barbosa BF, Moraes FCA de, Barbosa CB, Santos PTKP, Silva IP da, Silva BAA da, Barros JCM, Burbano RMR, Santos NPC dos, Fernandes MR. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, for obese patients: a systematic review and meta-analysis [Internet]. Journal of Personalized Medicine. 2023 ; 13[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/jpm13101460Vancouver
Barbosa BF, Moraes FCA de, Barbosa CB, Santos PTKP, Silva IP da, Silva BAA da, Barros JCM, Burbano RMR, Santos NPC dos, Fernandes MR. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, for obese patients: a systematic review and meta-analysis [Internet]. Journal of Personalized Medicine. 2023 ; 13[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/jpm13101460